Biomarkers

A new detector using photonics to identify E. coli bacteria from a tiny drop of blood, and produce a while-you-wait diagnosis in less than thirty minutes is making a bold bid to reduce the mortality rate from sepsis by more than 70%.

Phase II trial will analyse breath biomarkers to improve understanding of treatment effects, advancing the precision medicine agenda